Clinical Trial Detail

NCT ID NCT04080284
Title Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwell Health
Indications

uterine corpus serous adenocarcinoma

Therapies

Niraparib

Age Groups: senior adult

No variant requirements are available.